and congestive heart failure. However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions. This is especially true in HF ...

It is reasonable to assume that a large percentage of NYHA I patients will be identified as part of an evaluation for hypertension or heart disease. In both of these instances, β blockers are ...

A study from the University of Birmingham, UK, has indicated that the use of digoxin could lead to substantial cost savings ...

First used in 1785, this century-old medication is now emerging as a modern solution with significant healthcare benefits ...

Using a most cost-effective drug to treat some of the most common and dangerous heart conditions could save the NHS a ...

heart failure, chest pain and other cardiovascular problems. Churchwell added beta blockers are one of the most prescribed drugs to treat the heart. He said some doctors will use it to treat ...

However, the study did find a connection between beta-blockers and sleep problems. People taking these medications were more ...

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with heart disease.

Beta-blockers are widely used medications that help manage high blood pressure by reducing the heart rate and relaxing blood ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...